RESUMEN
An epidemic of morbidity and mortality has swept across the United States related to the use of prescription opioids for chronic noncancer pain. More than 100,000 people have died from unintentional overdose, making this one of the worst manmade epidemics in history. Much of health care delivery in the United States is regulated at the state level; therefore, both the cause and much of the cure for the opioid epidemic will come from state action. We detail the strong collaborations across executive health care agencies, and between those public agencies and practicing leaders in the pain field that have led to a substantial reversal of the epidemic in Washington State.
Asunto(s)
Analgésicos Opioides/envenenamiento , Dolor Crónico/tratamiento farmacológico , Sobredosis de Droga/prevención & control , Revisión de la Utilización de Medicamentos/legislación & jurisprudencia , Manejo del Dolor/normas , Mal Uso de Medicamentos de Venta con Receta/prevención & control , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/uso terapéutico , Sobredosis de Droga/etiología , Sobredosis de Droga/mortalidad , Revisión de la Utilización de Medicamentos/métodos , Revisión de la Utilización de Medicamentos/tendencias , Humanos , Medicaid/normas , Medicaid/tendencias , Manejo del Dolor/mortalidad , Manejo del Dolor/tendencias , Guías de Práctica Clínica como Asunto , Mal Uso de Medicamentos de Venta con Receta/legislación & jurisprudencia , Mal Uso de Medicamentos de Venta con Receta/estadística & datos numéricos , Estados Unidos , Washingtón/epidemiologíaRESUMEN
BACKGROUND: Gambling and tobacco smoking are highly comorbid among North American adults. However, there is a paucity of treatment options that are integrated (i.e. targeting both gambling and tobacco smoking simultaneously), accessible, and evidence based. METHODS: The aim of this two-arm open-label randomized controlled trial is to examine the effectiveness of an online, self-guided integrated treatment for problem gambling and tobacco smoking. A target sample of 214 participants will be recruited and be randomized into either an 8-week integrated or gambling only control condition. Both conditions will consist of seven online modules following cognitive behavioural therapy and motivational interviewing principles. Our three primary outcomes are (1) the number of days gambled, (2) money spent on gambling activities, and (3) time spent in gambling activities. Secondary outcomes include gambling disorder symptoms, cigarette use, and nicotine dependence symptoms. Assessments will be completed at baseline, at completion (i.e. 8 weeks from baseline), and at follow-up (i.e. 24 weeks from baseline). Generalized linear mixed modelling will be used to evaluate our primary and secondary outcomes. We expect that participants receiving online integrated treatment will show larger reductions in gambling relative to those receiving a control gambling only intervention. We further hypothesize that reductions in smoking will mediate these group differences. DISCUSSION: The rates of problem gambling and tobacco smoking are high in North America; yet, the treatment options for both are limited, with no integrated treatments available. If supported, our pilot study will be a cost-effective and accessible way to improve treatments for co-occurring problem gambling and tobacco use. TRIAL REGISTRATION: ClinicalTrials.gov NCT03614884 . Registered on August 3, 2019.